Merck’s cancer drug Keytruda booked sales of more than $2 billion for the first time in the fourth quarter. Photograph: Brendan McDermid/Reuters

Merck’s cancer immumotherapy Keytruda booked sales of more than $2 billion in a quarter for the first time, exceeding Wall Street’s lofty estimates an(...)

Merck’s total sales rose 5.4 per cent to $10.47 billion but  investors  expected bigger gains in market share for the cancer therapy. Photograph: Ralph Orlowski/Reuters

Merck & Co beat quarterly profit estimates on Friday as sales of its blockbuster drug Keytruda overtook rival Bristol-Myers Squibb’s Opdivo, but t(...)

US president Donald Trump: Many business leaders remain on his advisory panels and councils. These include Dell’s Michael Dell, Apple’s Tim Cook, IBM’s Ginny Rometty, Corning’s Wendell Weeks and GE’s Jeff Immelt. Photograph: Jim Watson/AFP/Getty

Since its arrival a decade ago, I’d wager Twitter has proven overall to be more of a thorn than a rose for most companies.  As a public-facing p(...)

A photograph taken on February 23rd, 2017, showing President Trump and Merck CEO Kenneth Frazier during a meeting with manufacturing CEOs in the White House. Photograph: Getty Imagescc

The resignation of Merck chief executive Kenneth Frazier from one of US president Donald Trump’s business panels has highlighted the growing tendency (...)

A worker  outside a Merck facility in  New Jersey, US, yesterday.  The  drugmaker  will eliminate  8,500 of its 81,000 global workforce  in its latest revamp. Photograph: Emile Wamsteker/Bloomberg

Merck, taking a cue from rival drugmakers that have slashed research spending to bolster earnings, has said it plans to cut annual operating costs by(...)